Dr. Stephanie Venn-Watson
๐ค SpeakerAppearances Over Time
Podcast Appearances
Even better. Even better. You're spot on. And then the third was low-calorie Mediterranean plus C15 supplementation. So it was a big lift to ask of C15. In those groups, not only did the third group, the C15 supplementation result in lower LDL cholesterol and improved gut microbiome,
Even better. Even better. You're spot on. And then the third was low-calorie Mediterranean plus C15 supplementation. So it was a big lift to ask of C15. In those groups, not only did the third group, the C15 supplementation result in lower LDL cholesterol and improved gut microbiome,
Even better. Even better. You're spot on. And then the third was low-calorie Mediterranean plus C15 supplementation. So it was a big lift to ask of C15. In those groups, not only did the third group, the C15 supplementation result in lower LDL cholesterol and improved gut microbiome,
But it also had the lowest, it had the greatest loss of liver fat, the greatest loss of body fat, the greatest glucose improvements, but it was trending. It was not statistically significant. You just kind of saw the step. But again, it was 12 weeks. And so the question is dosing, timing, things like that. In numerous studies, so these meta-analyses, studies of studies that prospectively follow
But it also had the lowest, it had the greatest loss of liver fat, the greatest loss of body fat, the greatest glucose improvements, but it was trending. It was not statistically significant. You just kind of saw the step. But again, it was 12 weeks. And so the question is dosing, timing, things like that. In numerous studies, so these meta-analyses, studies of studies that prospectively follow
But it also had the lowest, it had the greatest loss of liver fat, the greatest loss of body fat, the greatest glucose improvements, but it was trending. It was not statistically significant. You just kind of saw the step. But again, it was 12 weeks. And so the question is dosing, timing, things like that. In numerous studies, so these meta-analyses, studies of studies that prospectively follow
Thousands of people over decades, numerous studies have consistently shown people with higher C15, just like we saw in the dolphins, lower risk of developing type 2 diabetes, of heart disease, specifically coronary heart disease, of developing fatty liver disease and certain types of cancers, specifically a lot of work on colorectal cancer.
Thousands of people over decades, numerous studies have consistently shown people with higher C15, just like we saw in the dolphins, lower risk of developing type 2 diabetes, of heart disease, specifically coronary heart disease, of developing fatty liver disease and certain types of cancers, specifically a lot of work on colorectal cancer.
Thousands of people over decades, numerous studies have consistently shown people with higher C15, just like we saw in the dolphins, lower risk of developing type 2 diabetes, of heart disease, specifically coronary heart disease, of developing fatty liver disease and certain types of cancers, specifically a lot of work on colorectal cancer.
This is why with all these different aspects of the data from epidemiological data, clinical trials, mechanisms of action, in vivo efficacy studies, this is why Nick, Dr. Nick Shork, he was at ARDD, which is one of the world's leading anti-aging therapeutics meetings. He was in Copenhagen last year, and he presented C15. He said, listen, I've seen every longevity molecule before.
This is why with all these different aspects of the data from epidemiological data, clinical trials, mechanisms of action, in vivo efficacy studies, this is why Nick, Dr. Nick Shork, he was at ARDD, which is one of the world's leading anti-aging therapeutics meetings. He was in Copenhagen last year, and he presented C15. He said, listen, I've seen every longevity molecule before.
This is why with all these different aspects of the data from epidemiological data, clinical trials, mechanisms of action, in vivo efficacy studies, this is why Nick, Dr. Nick Shork, he was at ARDD, which is one of the world's leading anti-aging therapeutics meetings. He was in Copenhagen last year, and he presented C15. He said, listen, I've seen every longevity molecule before.
under the sun, and I've not seen a molecule that has more supportive data of being a longevity-enhancing molecule than C15.
under the sun, and I've not seen a molecule that has more supportive data of being a longevity-enhancing molecule than C15.
under the sun, and I've not seen a molecule that has more supportive data of being a longevity-enhancing molecule than C15.
Right, and it's like, what? So then, until now.
Right, and it's like, what? So then, until now.
Right, and it's like, what? So then, until now.
So probably not the groups that you're most excited about. Dairy fat, you know, by far is our primary source.
So probably not the groups that you're most excited about. Dairy fat, you know, by far is our primary source.